Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy

被引：0

作者：

Roberta Bovenzi

Claudio Liguori

Margherita Canesi

Marco D’Amelio

Maria Francesca De Pandis

Carmine Marini

Alessandra Monge

Alessandro Padovani

Alessandro Tessitore

Alessandro Stefani

Mario Zappia

机构：

[1] University of Rome Tor Vergata,Department of Systems Medicine

[2] University Hospital of Rome Tor Vergata,Parkinson’s Disease Unit

[3] ASST Gaetano Pini CTO,Parkinson Institute

[4] Moriggia Pelascini Hospital,U.O.C of Neurorehabilitation, Parkinson’s Disease and Movement Disorders Center

[5] Università Degli Studi di Palermo,Dipartimento Di Biomedicina, Neuroscienze e Diagnostica Avanzata

[6] San Raffaele University,Department of Human Sciences and Promotion of Quality of Life

[7] San Raffaele Cassino,Department of Biotechnological and Applied Clinical Sciences

[8] University of L’Aquila,Ospedale San Giovanni Battista

[9] ACISMOM,Neurology Unit, Department of Clinical and Experimental Sciences

[10] University of Brescia,Department of Advanced Medical and Surgery Sciences

[11] University of Campania “Luigi Vanvitelli”,Department “G.F. Ingrassia”, Section of Neurosciences

[12] University of Catania,undefined

来源：

Neurological Sciences | 2024年 / 45卷

关键词：

Parkinson’s disease; Safinamide; MAO-B inhibitor; Safety; Real-life evaluation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：573 / 583

页数：10

共 5 条

[1]

Olanow W(2016)Safinamide – a new therapeutic option to address motor symptoms and motor complications in mid- to late-stage Parkinson’s disease Eur Neurol Rev 11 2-15

[2]

Stocchi F(2019)Brain imaging and impulse control disorders in Parkinson’s disease Curr Neurol Neurosci Rep 19 67-undefined

[3]

Roussakis A(undefined)undefined undefined undefined undefined-undefined

[4]

Lao-Kaim NP(undefined)undefined undefined undefined undefined-undefined

[5]

Piccini P(undefined)undefined undefined undefined undefined-undefined

← 1 →